See Dr. Paul Sax's take in
HIV and ID Observations on why some insurers would like to limit the prescribing of HCV treatment.
The concept of limiting who prescribes therapy for hepatitis C virus infection isn't inherently wrong, says Dr. Paul Sax in the latest HIV and ID Observations blog post. But, he cautions, the decision about treatment should not be made by insurance companies.